CHANGZHOU, China, Sept. 30, 2025 /PRNewswire/ -- Trinasolar announced its Vertex N Shield module has been honored with the PV…
GUANGZHOU, China, Sept. 30, 2025 /PRNewswire/ -- At the opening of the 7th World New Energy Vehicle Congress (WNEVC) on…
PARIS, Sept. 17, 2025 /PRNewswire/ -- A new international study presented today at the European Academy of Dermatology and Venereology (EADV)…
September 09, 2025 11:00 ET | Source: Chiesi Global Rare Diseases Results presented focus on clinical insights on Fabry disease…
Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American…
- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society…
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All Prespecified Subgroups Company to…
26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsiesData include an…
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing…
Initial results from the First in Human (FIH) Phase 1 trial evaluating AIC468, a 2nd generation antisense oligonucleotide (ASO), in…